University of Houston's Fentanyl Vaccine to Enter Clinical Trials

Sep 2, 2024, 11:28 AM

Researchers at the University of Houston have developed a fentanyl vaccine that is set to enter clinical trials by mid-next year. The vaccine has shown success in animal studies and is designed to prevent the highly addictive opioid from entering the brain, thereby reducing the risk of overdose. This initiative aims to provide a groundbreaking solution to the ongoing opioid crisis.